Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × daromun × Dermatologic × Clear all

Phase

Status

Unknown 2 Recruiting 2 Not yet recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 72 Nivolumab 51 Ipilimumab 30 Specimen Handling 15 trametinib 14 Magnetic Resonance Spectroscopy 14 Cyclophosphamide 12 Biopsy 12 dabrafenib 11 cemiplimab 11 avelumab 11 binimetinib 10 Radiotherapy 10 CTLA-4 Antigen 10 Radiosurgery 9 fludarabine 7 encorafenib 7 atezolizumab 7 Immunoglobulin G 7 Disulfides 7 Cisplatin 7 relatlimab 6 lenvatinib 6 durvalumab 6 Paclitaxel 6 Carboplatin 6 tislelizumab 5 fludarabine phosphate 5 dostarlimab 5 Pemetrexed 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02938299 2024-09-19

Pivotal

Philogen S.p.A.

Phase 3 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡